BioMarin Gene Therapy Yields Dramatic Results In Hemophilia

A new gene therapy for hemophilia, a deadly disease in which blood does not clot, may allow most patients to live normal lives.

Source: Forbes.com Healthcare News - July 27, 2016 Category: Pharmaceuticals Authors: Matthew Herper Source Type: news